4123 logo

Center Laboratories, Inc. Stock Price

TPEX:4123 Community·NT$26.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4123 Share Price Performance

NT$35.90
-11.88 (-24.86%)
NT$35.90
-11.88 (-24.86%)
Price NT$35.90

4123 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk and slightly overvalued.

3 Risks
2 Rewards

Center Laboratories, Inc. Key Details

NT$1.6b

Revenue

NT$900.4m

Cost of Revenue

NT$664.8m

Gross Profit

-NT$1.1b

Other Expenses

NT$1.8b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
2.38
42.48%
113.51%
22.7%
View Full Analysis

About 4123

Founded
1959
Employees
n/a
CEO
Su-Chi Wang
WebsiteView website
www.centerlab.com.tw

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretics and analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. It also offers central nervous system medication consisting of treatments for cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and Parkinson's disease, as well as provides treatment for diabetes and pancreatic beta cells. In addition, the company engages in drug development, cell therapy, biotechnology, hydrogen energy, and dairy business. Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei City, Taiwan.

Recent 4123 News & Updates

Recent updates

No updates